Literature DB >> 23683736

Serial morphological and functional assessment of drug-eluting balloon for in-stent restenotic lesions: mechanisms of action evaluated with angiography, optical coherence tomography, and fractional flow reserve.

Pierfrancesco Agostoni1, Anouar Belkacemi, Michiel Voskuil, Hendrik M Nathoe, Pieter A Doevendans, Pieter R Stella.   

Abstract

OBJECTIVES: This study sought to elucidate the underlying mechanism through which drug-eluting balloons (DEB) restore coronary blood flow, by assessing the coronary vessel before, immediately after, and at 6-month follow-up with angiography, optical coherence tomography (OCT), and fractional flow reserve (FFR).
BACKGROUND: In-stent restenosis (ISR) treatment remains challenging. Drug-eluting balloons have been shown to be a valid treatment option in several studies. These studies focused on efficiency of the device, whereas the mechanisms of action of DEB in ISR treatment have not been investigated.
METHODS: In this prospective, single-center observational study, patients with ISR were treated with a second-generation DEB. Serial angiographic, OCT, and FFR measurements were performed before and after the procedure, as well as at 6-month follow-up.
RESULTS: Twenty-five patients were assigned to DEB treatment, with an angiographic and device success of 100% and 92%, respectively. Late luminal loss was 0.01 ± 0.43 mm. Median percent changes [interquartile range] between pre-and post-procedure, and post-procedure and follow-up were, respectively: lumen volume 75.1% increase [43.7 to 115.0], and 8% increase [-14.0 to 25.8]; stent volume 23.7% increase [15.5 to 40.0], and -1.2% decrease [-6.9 to 5.9]; and neointimal volume -14.4% decrease [-29.2 to -9.5], and -15.8% decrease [-38.1 to 28.3]. The FFR gradient along the treated stent (difference in FFR between the distal and the proximal stent edge) was 0.37 ± 0.18 pre-procedure, 0.06 ± 0.04 post-procedure, and 0.05 ± 0.05 at follow-up. In all post-procedural OCT images, intrastent dissections were seen, which were sealed at follow-up OCT.
CONCLUSIONS: DEB restore coronary blood flow by means of a short-term mechanical effect, causing an increase in lumen and stent volumes and compression of neointimal hyperplasia (with intra-stent dissections). Due to the local drug effect, patency persists and may even improve at follow-up, with further increase in lumen volume, decrease in neointimal volume, and complete sealing of neointimal dissections.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23683736     DOI: 10.1016/j.jcin.2012.12.132

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  6 in total

1.  Localized in vivo model drug delivery with intravascular ultrasound and microbubbles.

Authors:  Joseph P Kilroy; Alexander L Klibanov; Brian R Wamhoff; Douglas K Bowles; John A Hossack
Journal:  Ultrasound Med Biol       Date:  2014-08-15       Impact factor: 2.998

2.  Drug-coated balloon angioplasty for severe pulmonary vein stenosis resulting from cryoballoon ablation for atrial fibrillation.

Authors:  Koji Yamaguchi; Tetsuzo Wakatsuki; Tomomi Matsuura; Kazuhisa Matsumoto; Yutaka Kawabata; Muneyuki Kadota; Kenya Kusunose; Takayuki Ise; Shusuke Yagi; Daiju Fukuda; Hirotsugu Yamada; Takeshi Soeki; Masataka Sata
Journal:  J Cardiol Cases       Date:  2022-03-29

Review 3.  Drug-coated balloon therapy in coronary and peripheral artery disease.

Authors:  Robert A Byrne; Michael Joner; Fernando Alfonso; Adnan Kastrati
Journal:  Nat Rev Cardiol       Date:  2013-11-05       Impact factor: 32.419

4.  Treatment of In-Stent Restenosis by Excimer Laser Coronary Atherectomy and Drug-Coated Balloon: Serial Assessment with Optical Coherence Tomography.

Authors:  Toru Miyazaki; Takashi Ashikaga; Taku Fukushima; Yu Hatano; Taro Sasaoka; Ken Kurihara; Yuichi Ono; Shigeo Shimizu; Kenichiro Otomo; Kenzo Hirao
Journal:  J Interv Cardiol       Date:  2019-04-18       Impact factor: 2.279

5.  Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis.

Authors:  Freek Nijhoff; Pieter R Stella; Maartje S Troost; Anouar Belkacemi; Hendrik M Nathoe; Michiel Voskuil; Mariam Samim; Pieter A Doevendans; Pierfrancesco Agostoni
Journal:  Clin Res Cardiol       Date:  2015-11-05       Impact factor: 5.460

6.  Clinical outcomes in patients treated for coronary in-stent restenosis with drug-eluting balloons: Impact of high platelet reactivity.

Authors:  Adrienn Tornyos; Dániel Aradi; Iván G Horváth; Attila Kónyi; Balázs Magyari; Tünde Pintér; András Vorobcsuk; Dániel Tornyos; András Komócsi
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.